Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

The association of polymorphisms in 5-fluorouracil metabolism genes with outcome in adjuvant treatment of colorectal cancer

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Reappraisal of the genetic diversity and pharmacogenetic assessment of CES1

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Rationale and design of the multiethnic Pharmacogenomics in Childhood Asthma consortium

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Individualization of treatments with drugs metabolized by CES1: combining genetics and metabolomics

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Long-term benefits and harms associated with genetic cholesteryl ester transfer protein deficiency in the general population

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. HIV infection is associated with type 2 diabetes mellitus

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  3. Occupational inhalant exposures and longitudinal lung function decline

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
The purpose of this study was to investigate whether specific combinations of polymorphisms in 5-fluorouracil (5-FU) metabolism-related genes were associated with outcome in 5-FU-based adjuvant treatment of colorectal cancer.
OriginalsprogEngelsk
TidsskriftPharmacogenomics
Vol/bind12
Udgave nummer9
Sider (fra-til)1257-67
Antal sider11
ISSN1462-2416
DOI
StatusUdgivet - 2011

ID: 33169203